3/5
02:22 pm
arvn
Arvinas (ARVN) had its price target raised by Citigroup Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
Arvinas (ARVN) had its price target raised by Citigroup Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
3/4
10:57 am
arvn
Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference [Yahoo! Finance]
Low
Report
Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference [Yahoo! Finance]
3/3
10:05 am
arvn
Prostate Cancer Market Competitive Landscape Report 2026: Comprehensive Insights About 230+ Companies and 265+ Drugs by Product Type, Stage, and Route of Administration [Yahoo! Finance]
Low
Report
Prostate Cancer Market Competitive Landscape Report 2026: Comprehensive Insights About 230+ Companies and 265+ Drugs by Product Type, Stage, and Route of Administration [Yahoo! Finance]
3/2
04:10 am
arvn
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials [Yahoo! Finance]
Low
Report
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials [Yahoo! Finance]
3/2
01:00 am
arvn
Low
Report
2/25
09:39 am
arvn
Arvinas (ARVN) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $20.00 price target on the stock, up from $16.00.
Low
Report
Arvinas (ARVN) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $20.00 price target on the stock, up from $16.00.
2/24
07:03 pm
arvn
Arvinas Inc (ARVN) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges with ... [Yahoo! Finance]
Medium
Report
Arvinas Inc (ARVN) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges with ... [Yahoo! Finance]
2/24
03:08 pm
arvn
Arvinas (ARVN) had its "neutral" rating reaffirmed by Wedbush.
Low
Report
Arvinas (ARVN) had its "neutral" rating reaffirmed by Wedbush.
2/24
02:11 pm
arvn
Arvinas (ARVN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Arvinas (ARVN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/24
12:43 pm
arvn
Arvinas, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Arvinas, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/24
10:56 am
arvn
Arvinas Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Arvinas Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
07:00 am
arvn
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Medium
Report
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2/23
10:12 am
arvn
Arvinas Inc (ARVN) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Arvinas Inc (ARVN) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/23
07:18 am
arvn
Arvinas to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Arvinas to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/23
07:00 am
arvn
Arvinas to Participate in Upcoming Investor Conferences
Low
Report
Arvinas to Participate in Upcoming Investor Conferences
2/22
02:02 am
arvn
Medium
Report
2/17
07:13 am
arvn
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 [Yahoo! Finance]
Low
Report
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 [Yahoo! Finance]
2/17
07:00 am
arvn
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Low
Report
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
2/12
08:19 am
arvn
Arvinas appoints new president and CEO; leadership transition announced [Seeking Alpha]
High
Report
Arvinas appoints new president and CEO; leadership transition announced [Seeking Alpha]
2/12
07:00 am
arvn
Arvinas Announces Appointment of Randy Teel, Ph.D., as President, Chief Executive Officer, and Director
High
Report
Arvinas Announces Appointment of Randy Teel, Ph.D., as President, Chief Executive Officer, and Director
2/10
05:31 pm
arvn
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
Low
Report
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
2/10
05:31 pm
arvn
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
Low
Report
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
1/22
12:01 am
arvn
New nanoparticle technology offers hope for hard-to-treat diseases [Yahoo! Finance]
Low
Report
New nanoparticle technology offers hope for hard-to-treat diseases [Yahoo! Finance]
1/12
06:12 am
arvn
Here's Why We're Not Too Worried About Arvinas' (NASDAQ:ARVN) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Not Too Worried About Arvinas' (NASDAQ:ARVN) Cash Burn Situation [Yahoo! Finance]
1/6
07:07 am
arvn
Arvinas (NASDAQ:ARVN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Low
Report
Arvinas (NASDAQ:ARVN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.